CM-24 is under clinical development by Purple Biotech and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success rate ...
Mark Spain, 64, who spent decades anchoring the news in Indianapolis, Cleveland, and Jacksonville, died on Dec. 18.
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Non-Small Cell Lung Cancer.
LYNCHBURG, Va. (WSET) — A celebration of life will be held for ABC13's Mark Spain on Saturday, January 4. The service will be ...
Earlier this month, the Lynchburg community participated in a Purple Out day for Spain after it was learned he was diagnosed with Stage 4 pancreatic cancer. Liberty University lit up its Freedom ...
Purple Biotech has identified a new serum biomarker, CEACAM1, which may significantly enhance the efficacy of their oncology therapeutic candidate, CM24, for treating metastatic pancreatic cancer.
With Christmas around the corner, Bryony Thomas was dealt a devastating blow. Her incredible journey through adversity is a ...
Mark Spain, a popular veteran news anchor for WSET-TV in Lynchburg, Virginia, has died at the age of 64 following a battle ...
“One was wearing the purple Macmillan uniform so I knew it was cancer. While Tom and I were deeply shocked it was pancreatic cancer, which we knew was the one you don’t want to get, we weren’t all ...
“One was wearing the purple Macmillan uniform so I knew it was cancer. While Tom and I were deeply shocked it was pancreatic cancer, which we knew was the one you don’t want to get, we weren ...